Oral MS Drug Fampridine is Trifecta of Firsts for People with MS, Says National MS Society

FDA approves fampridine SR, now called Ampyra, to improve walking for people with all types of multiple sclerosis. Ampyra is the first symptom management drug developed specifically to treat MS, the first oral therapy approved for MS and the first new FDA-approved therapy for MS since 2004.

(PRWeb January 23, 2010)

Read the full story at http://www.prweb.com/releases/Ampyra/multiple_sclerosis/prweb3503694.htm